306 related articles for article (PubMed ID: 31118657)
1. Medulloblastoma: optimizing care with a multidisciplinary approach.
Thomas A; Noël G
J Multidiscip Healthc; 2019; 12():335-347. PubMed ID: 31118657
[TBL] [Abstract][Full Text] [Related]
2. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: "Onset of the molecular era".
Dhanyamraju PK; Patel TN; Dovat S
Mol Biol Rep; 2020 Dec; 47(12):9931-9937. PubMed ID: 33159234
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol. 2013; 6(7): 1211-22.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2015; 8(9):11945. PubMed ID: 26617952
[TBL] [Abstract][Full Text] [Related]
6. Current medulloblastoma subgroup specific clinical trials.
Thompson EM; Ashley D; Landi D
Transl Pediatr; 2020 Apr; 9(2):157-162. PubMed ID: 32477916
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Models of Craniospinal Irradiation for Medulloblastoma.
Stripay JL; Merchant TE; Roussel MF; Tinkle CL
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31948065
[No Abstract] [Full Text] [Related]
8. The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies.
Slika H; Alimonti P; Raj D; Caraway C; Alomari S; Jackson EM; Tyler B
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568705
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
10. Current therapy for medulloblastoma.
Gottardo NG; Gajjar A
Curr Treat Options Neurol; 2006 Jul; 8(4):319-34. PubMed ID: 16942675
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.
Seidel C; Heider S; Hau P; Glasow A; Dietzsch S; Kortmann RD
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885055
[TBL] [Abstract][Full Text] [Related]
13. Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
Moxon-Emre I; Taylor MD; Bouffet E; Hardy K; Campen CJ; Malkin D; Hawkins C; Laperriere N; Ramaswamy V; Bartels U; Scantlebury N; Janzen L; Law N; Walsh KS; Mabbott DJ
J Clin Oncol; 2016 Dec; 34(34):4161-4170. PubMed ID: 27507873
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy Advances in Paediatric Medulloblastoma Treatment.
Padovani L; Horan G; Ajithkumar T
Clin Oncol (R Coll Radiol); 2019 Mar; 31(3):171-181. PubMed ID: 30655168
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
[TBL] [Abstract][Full Text] [Related]
16. Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.
Ray S; Chaturvedi NK; Bhakat KK; Rizzino A; Mahapatra S
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054230
[TBL] [Abstract][Full Text] [Related]
17. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
[TBL] [Abstract][Full Text] [Related]
18. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S
J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192
[TBL] [Abstract][Full Text] [Related]
20. Case-based review: pediatric medulloblastoma.
Kline CN; Packer RJ; Hwang EI; Raleigh DR; Braunstein S; Raffel C; Bandopadhayay P; Solomon DA; Aboian M; Cha S; Mueller S
Neurooncol Pract; 2017 Sep; 4(3):138-150. PubMed ID: 29692919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
